Literature DB >> 22124459

Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.

Anna Krause1, Anna Jelińska, Judyta Cielecka-Piontek, Maria Klawitter, Przemysław Zalewski, Irena Oszczapowicz, Małgorzata Wąsowska.   

Abstract

The stability of N-[(morpholine)methylene]-daunorubicin hydrochloride (MMD) was investigated in the pH range 0.44-13.54, at 313, 308, 303 and 298 K. The degradation of MMD as a result of hydrolysis is a pseudo-first-order reaction described by the following equation: ln c = ln c(0) - k(obs)• t. In the solutions of hydrochloric acid, sodium hydroxide, borate, acetate and phosphate buffers, k(obs) = k(pH) because general acid-base catalysis was not observed. Specific acid-base catalysis of MMD comprises the following reactions: hydrolysis of the protonated molecules of MMD catalyzed by hydrogen ions (k(1)) and spontaneous hydrolysis of MMD molecules other than the protonated ones (k(2)) under the influence of water. The total rate of the reaction is equal to the sum of partial reactions: k(pH) = k(1) • a(H)+ • f(1) + k(2) • f(2) where: k(1) is the second-order rate constant (mol(-1) l s(-1)) of the specific hydrogen ion-catalyzed degradation of the protonated molecules of MMD; k(2) is the pseudo-first-order rate constant (s(-1)) of the water-catalyzed degradation of MMD molecules other than the protonated ones, f(1) - f(2) are fractions of the compound. MMD is the most stable at approx. pH 2.5.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124459     DOI: 10.3109/03639045.2011.637053

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  The influence of pH and temperature on the stability of N-[(piperidine)methylene]daunorubicin Hydrochloride and a comparison of the stability of daunorubicin and its four new amidine derivatives in aqueous solutions.

Authors:  Mikołaj Piekarski; Agnieszka Dołhań; Judyta Cielecka-Piontek; Przemysław Zalewski; Witold Kycler; Aleksandra Kaczmarek; Artur Firlej; Irena Oszczapowicz; Anna Jelińska
Journal:  ScientificWorldJournal       Date:  2014-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.